We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00769145
Recruitment Status : Completed
First Posted : October 8, 2008
Last Update Posted : July 11, 2017
Genentech, Inc.
Information provided by (Responsible Party):
Sonia Yoo, University of Miami

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2011
  Study Completion Date : March 2012